🇺🇸 FDA
Patent

US 8480995

Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic efficacy of chemotherapy agents, and a rapid process for preparing sodium selenosulfate

granted A61KA61K33/04A61K45/06

Quick answer

US patent 8480995 (Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic efficacy of chemotherapy agents, and a rapid process for preparing sodium selenosulfate) held by UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA
Grant date
Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K33/04, A61K45/06, A61P, A61P3/02